Terms of Service — Medroxa

Last updated: July 13, 2026
Effective date: July 13, 2026

1. Agreement to terms

These Terms of Service (“Terms”) govern access to and use of the Medroxa clinical decision-support platform (the “Service”) operated by Medroxa (“we,” “us,” or “our”).

By creating an account, signing in, continuing with Google, subscribing to a paid plan, or submitting a clinical analysis, you agree to these Terms and our Privacy Policy.

If you use the Service on behalf of an organization, you represent that you have authority to bind that organization, and “you” includes the organization.

Order of precedence (enterprise): For customers with a signed Order Form, Master Services Agreement (MSA), Data Processing Agreement (DPA), or Business Associate Agreement (BAA), those documents control over these Terms where they conflict.

2. Service description

Medroxa provides preliminary clinical decision-support for licensed pharmacists, prescribers, and authorized pharmacy/clinical staff, including:

Medication therapy management (MTM) tools
Drug interaction, dosing, allergy, and side-effect analysis
Prescription reading and medical document OCR
Medical imaging OCR and clinical calculators
AI-assisted reference and transcription features

The Service is not a substitute for professional medical judgment, diagnosis, treatment, or emergency care. All outputs are drafts requiring independent verification by a licensed clinician.

3. Eligibility and authorized users

3.1 Who may use the Service

Licensed or supervised pharmacy and clinical professionals, or staff authorized by their employer
Users 18 years of age or older
Users in jurisdictions where the Service may lawfully be offered

3.2 Account types

Type	Description
Individual	Self-serve registration (email or Google)
Team	Multi-seat subscription with shared organizational use
Enterprise	Custom deployment, BAA/DPA, SSO, audit export, and dedicated support (by agreement)

3.3 Administrator responsibilities (Team / Enterprise)

Organization administrators are responsible for:

Issuing and revoking user access
Ensuring workforce training on de-identification and appropriate use
Executing BAA/DPA before PHI is processed, where required
Compliance with applicable pharmacy, medical, and privacy regulations

4. Acceptable use

You agree not to:

Enter patient data without legal authorization or a executed BAA where PHI is involved
Use prescription tools for controlled or scheduled substances
Deploy the Service publicly without access controls
Rely on AI output as definitive diagnosis, prescribing, or treatment without clinician review
Reverse engineer, scrape, or overload the Service (except as permitted by law)
Share credentials or circumvent usage limits or entitlements
Upload malware, unlawful content, or data you are not authorized to process
Misrepresent credentials, licensure, or affiliation

We may suspend or terminate access for violations, abuse, or security risk.

5. Clinical and AI disclaimers

5.1 Not medical advice

Outputs are for educational and clinical decision-support purposes only. They do not replace human clinical judgment or guide individual patient care without licensed review.

5.2 Artificial intelligence

You acknowledge that:

Outputs are generated by artificial intelligence (Microsoft Azure OpenAI and related models per deployment), not a human healthcare professional
AI may produce errors, omissions, or outdated information
Human review is mandatory before any clinical action
Controlled substances cannot be processed in prescription generation tools

See Legal Notices & Disclaimer for full warranty and liability disclaimers.

5.3 Your responsibility

You and your employing organization remain solely responsible for clinical decisions, regulatory compliance, and patient safety.

6. Health data and privacy

Use of the Service is governed by our Privacy Policy and Clinical Data Consent.

You agree to:

Enter de-identified clinical context unless PHI processing is authorized under a BAA
Not submit unnecessary identifiers (names, national IDs, phone numbers, etc.)
Maintain appropriate organizational policies for workforce use

Default technical posture: Clinical content in tool forms is processed in server memory for the request duration and is not stored in a clinical database unless configured for enterprise retention.

7. Enterprise, HIPAA, and business associate terms

7.1 HIPAA and PHI

Medroxa supports HIPAA-aligned controls when deployed with appropriate agreements. The Service is not automatically HIPAA-compliant for all use cases.

Processing PHI on behalf of a covered entity requires a countersigned Business Associate Agreement (BAA)
Stripe processes billing data only, not clinical PHI in prompts
Azure OpenAI PHI processing requires an eligible Microsoft BAA and compliant regional deployment

7.2 Enterprise features (by agreement)

Enterprise plans may include:

Custom DPA and BAA execution
Audit log export
Regional data residency options
SSO / directory integration (roadmap)
Dedicated support and security review
Custom retention and subprocessors notice

8. Subscriptions, billing, and refunds

8.1 Paid plans

Paid tiers (Essential, Professional, Clinical, Hospital) are billed monthly or annually through Stripe Checkout and the Stripe Customer Portal. Hospital is custom / contact-us and is not sold via self-serve checkout.

Prices are displayed on the pricing page and in-app before checkout
Subscriptions renew automatically until canceled
Taxes may apply based on your jurisdiction

8.2 Refunds

You may request a full refund within 14 days of your first paid subscription charge if you have not substantially used paid-tier limits (more than 50 clinical runs or 5 vision uploads). Contact support with your account email.

After 14 days, fees are non-refundable except where required by applicable law. Downgrading does not entitle you to a prorated refund unless mandated by law.

8.3 Cancellation

You may cancel anytime via the Stripe Customer Portal or by contacting support. Access continues until the end of the current billing period, then reverts to the Free tier (subject to Free tier limits).

8.4 Free tier

The Free tier includes limited tools and daily usage caps. We may adjust Free tier limits with reasonable notice. Abuse may result in suspension.

8.5 PCI

Card data is handled exclusively by Stripe (PCI DSS). Medroxa does not store card numbers.

9. Intellectual property

9.1 Our IP

The Service, software, documentation, branding, and clinical prompt libraries are owned by Medroxa or its licensors. These Terms grant a limited, non-exclusive, non-transferable license to use the Service during your subscription or account term.

9.2 Your content

You retain ownership of clinical inputs you submit. You grant Medroxa a limited license to process inputs solely to provide the Service and as described in the Privacy Policy. We do not claim ownership of your clinical content.

9.3 Feedback

Suggestions or feedback may be used to improve the Service without obligation to you.

10. Confidentiality

Each party will protect the other’s confidential information with reasonable care. Clinical inputs are treated as confidential and processed per the Privacy Policy and any executed DPA/BAA.

11. Service availability and support

11.1 Availability

We strive for reliable operation but do not guarantee uninterrupted access. Maintenance, third-party outages (Azure, Stripe), or force majeure may affect availability.

Enterprise SLAs (uptime credits, response times) are available only under a signed enterprise agreement.

11.2 Support

Standard support: email and in-app contact. Enterprise customers may receive prioritized support per Order Form.

12. Limitation of liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW:

THE SERVICE IS PROVIDED “AS IS” AND “AS AVAILABLE” WITHOUT WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT
MEDROXA IS NOT LIABLE FOR SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING LOSS OF PROFITS, DATA, OR CLINICAL OUTCOMES
TOTAL LIABILITY FOR ALL CLAIMS IN ANY 12-MONTH PERIOD IS LIMITED TO THE GREATER OF (A) AMOUNTS YOU PAID TO MEDROXA IN THAT PERIOD OR (B) USD $100, EXCEPT WHERE LIABILITY CANNOT BE LIMITED BY LAW

Nothing in these Terms limits liability for fraud, gross negligence, or death/personal injury caused by negligence where prohibited by law.

Clinical liability remains with the authorized user and their employing organization.

13. Indemnification

You agree to indemnify and hold Medroxa harmless from claims arising from:

Your clinical decisions or misuse of outputs
Unauthorized PHI submission or breach of your organization's policies
Violation of these Terms or applicable law
Infringement caused by content you submit

Enterprise agreements may modify indemnification scope.

14. Term and termination

14.1 Term

These Terms apply while you have an active account or subscription.

14.2 Termination by you

You may stop using the Service and cancel subscriptions at any time.

14.3 Termination by us

We may suspend or terminate access for Terms violations, non-payment, security risk, or discontinuation of the Service (with reasonable notice where practicable).

14.4 Effect of termination

Upon termination, your right to use the Service ends. Provisions that by nature should survive (liability limits, indemnity, IP, governing law) survive. PHI return/destruction is governed by the BAA/DPA where applicable.

15. Export and sanctions

You may not use the Service in violation of U.S. export controls, sanctions, or applicable trade restrictions.

16. Governing law and disputes

These Terms are governed by the laws of the State of California, United States, without regard to conflict-of-law principles, unless your enterprise agreement specifies otherwise.

Disputes should first be addressed through good-faith support contact. Where permitted, parties agree to binding arbitration or courts in Alameda County, California, except for injunctive relief for IP or confidentiality breaches.

EU/UK consumers may retain mandatory rights under local consumer protection law.

17. Changes to terms

We may update these Terms. Material changes will be posted with an updated Last updated date. Continued use after notice constitutes acceptance where permitted. Enterprise customers may receive direct notice per contract.

18. Contact

Terms, billing, and enterprise inquiries

Mohammadamin Asadirad
Cell: (209) 684-2978
Cell: (925) 529-2345
Email: support@medroxa.com

19. Related documents

This document is a technical compliance template. It does not constitute legal advice. Consult qualified legal counsel for binding compliance decisions.